The half-life of semaglutide is approximately 7 days, or about one week. This means that seven days after your last dose, roughly half the drug remains in your bloodstream. This unusually long half-life is why semaglutide (sold as Ozempic, Wegovy, and Rybelsus) is dosed just once per week, unlike older medications in the same class that required daily injections.
Why Semaglutide Lasts So Long
Semaglutide is a synthetic version of GLP-1, a hormone your gut naturally releases after eating. The natural hormone breaks down in minutes. Semaglutide lasts days instead because it’s been engineered with a fatty acid chain attached to its structure. That chain latches onto a protein in your blood called albumin, which acts like a protective shuttle, shielding semaglutide from the enzymes that would normally chew it up quickly.
When the body does eventually break semaglutide down, it happens through the same process used on other proteins: the peptide backbone gets snipped apart, and the fatty acid side chain is broken down through a process called beta-oxidation. About 53% of the drug’s byproducts leave through urine, and roughly 19% through feces. Only about 3% of the original dose is excreted intact in urine, meaning the vast majority gets metabolized before it leaves.
How Long Semaglutide Stays in Your System
A common rule of thumb is that it takes about five half-lives for a drug to be effectively cleared from your body. With a 7-day half-life, that works out to roughly 5 weeks after your last injection. During that time, effects gradually fade rather than stopping abruptly.
This extended clearance period matters in a few practical situations. If you’re planning a pregnancy, for instance, prescribers typically recommend stopping semaglutide at least 2 months before trying to conceive, building in a buffer beyond the 5-week clearance window. It also matters if you’re switching to a different medication or preparing for surgery where GLP-1 drugs may affect anesthesia protocols.
Injectable vs. Oral: Same Half-Life
The half-life is approximately the same whether you take semaglutide as a weekly injection (Ozempic or Wegovy) or as a daily oral tablet (Rybelsus). The difference between these formulations is absorption, not elimination. The oral version requires daily dosing because only a small fraction of each tablet gets absorbed through the stomach lining, not because the drug breaks down faster once it’s in your blood. Once semaglutide reaches the bloodstream, it behaves the same way regardless of how it got there.
Kidney and Liver Problems Don’t Change It
Because semaglutide is broken down through protein metabolism rather than processed heavily by the kidneys or liver, its half-life stays remarkably stable across different health conditions. FDA clinical pharmacology reviews show that people with mild, moderate, or even severe kidney impairment had comparable drug exposure to those with normal kidney function. People with end-stage kidney disease on dialysis showed no meaningful change either, and dialysis itself didn’t remove the drug.
The same holds true for liver impairment. People with mild, moderate, and severe liver disease showed drug exposure nearly identical to those with normal liver function. As a result, no dose adjustments are needed for kidney or liver problems at any severity level.
What the Half-Life Means for Missed Doses
The week-long half-life gives you a practical cushion if you miss a dose. For Ozempic, you can take a missed dose up to 5 days late. If more than 5 days have passed, you skip it and wait for your next scheduled injection. For Wegovy, the window is tighter: you can take the missed dose as long as your next scheduled dose is more than 2 days away.
Where the half-life becomes less forgiving is if you miss multiple weeks. Your body builds tolerance to semaglutide gradually during the dose-escalation phase, and that tolerance fades as the drug clears. If you’ve missed two or more consecutive weeks, jumping back in at your previous dose can cause significant nausea, vomiting, and stomach pain. In that situation, restarting at a lower dose and working back up is the typical approach to avoid those side effects.
How It Compares to Similar Drugs
Semaglutide’s 7-day half-life sits in the middle of the GLP-1 drug class. Liraglutide (Saxenda, Victoza) has a half-life of about 13 hours, which is why it requires daily injections. Dulaglutide (Trulicity) has a half-life of roughly 5 days, also dosed weekly. Tirzepatide (Mounjaro, Zepbound) comes in at about 5 days as well. Semaglutide’s longer half-life compared to these weekly competitors means it maintains more stable blood levels between doses, which may contribute to more consistent appetite suppression throughout the week.